Radical Surgery for Gallbladder Carcinoma: Possibilities of Survival
Overview
Authors
Affiliations
Background/aims: An aggressive surgical approach in the management of gallbladder cancer (GBC) has improved survival significantly in recent years. The aim of this retrospective study is to evaluate the long-term results of surgical treatment of GBC reassessed following the TNM staging system of the AJCC-2002.
Methodology: The present series considers 118 patients with GBC treated between 1982 and 2003. Seventy-four cases (63%) were females and 44 (37%) males; overall age was 63 years (range 38-91).
Results: Among the 118 patients with GBC, 35 (36%) underwent radical surgery: 3 pTNM IA [3 cholecystectomy (CT)], 10 IB [3CT, 3 CT + hepatic resection (HR), 4 HR], 3 IIA (3 HR), 7 IIB (3 CT+HR+ bile duct resection (BDR), 3 HR, 1 hepatopancreatoduodenectomy +CT), 10 III [4 CT+HR, 5 extensive HR (eHR), 1 HR+right colectomy+BDR+total gastrectomy], 2 IV (2 eHR). Overall 1-, 3-, 5-year survival was 67%, 46%, 34% respectively for stage IA-IB; 63%,12%, 12% for IIA-IIB; 50%, 30%, 30% for III-IV (p=ns); in particular, 1-, 3-, 5-year survival was 100%, 100%, 100% for T1a; 50%, 50%, 50% for T1b; 70%, 46%, 35% for T2; 50%, 12%, 12% for T3; 54%, 32%, 32% for T4 (p=ns); 1-, 3-, 5-year survival for patients without lymph node involvement was 58%, 44%, 37% and 60%, 15%, 15% for patients with lymph node metastases (p=ns), respectively.
Conclusions: CT seems to be sufficient in T1a GBC patients but inadequate in T1b (stage IA), which requires a more aggressive approach. In stage IIB, III and IV, the presence of lymph-node metastasis is not a contraindication to aggressive surgery.
Singh D, Singh P, Mandal A, Rakesh A Indian J Surg Oncol. 2024; 15(Suppl 2):196-203.
PMID: 38817991 PMC: 11133252. DOI: 10.1007/s13193-024-01925-x.
Pehlivanoglu B, Akkas G, Memis B, Basturk O, Reid M, Saka B Virchows Arch. 2022; 482(2):311-323.
PMID: 36580138 DOI: 10.1007/s00428-022-03482-6.
The Landmark Series: Gallbladder Cancer.
Gamboa A, Maithel S Ann Surg Oncol. 2020; 27(8):2846-2858.
PMID: 32474816 DOI: 10.1245/s10434-020-08654-9.
Updates on Gallbladder Cancer Management.
Yahya Zaidi M, Maithel S Curr Oncol Rep. 2018; 20(2):21.
PMID: 29500514 DOI: 10.1007/s11912-018-0664-3.
Singh S, Talwar R, Kannan N, Tyagi A, Jaiswal P, Kumar A J Gastrointest Cancer. 2017; 49(3):268-274.
PMID: 28367607 DOI: 10.1007/s12029-017-9940-y.